These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 15794718

  • 1. The risk/benefit of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Bonay M, Bancal C, Crestani B.
    Expert Opin Drug Saf; 2005 Mar; 4(2):251-71. PubMed ID: 15794718
    [Abstract] [Full Text] [Related]

  • 2. Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Bonay M, Bancal C, Crestani B.
    Drug Saf; 2002 Mar; 25(1):57-71. PubMed ID: 11820912
    [Abstract] [Full Text] [Related]

  • 3. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA.
    Pulm Pharmacol Ther; 2008 Mar; 21(3):540-50. PubMed ID: 18280761
    [Abstract] [Full Text] [Related]

  • 4. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH, Kim YS, Linton JA, Nam CM, Choi Y, Park EC.
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [Abstract] [Full Text] [Related]

  • 5. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
    Gershon AS, Campitelli MA, Croxford R, Stanbrook MB, To T, Upshur R, Stephenson AL, Stukel TA.
    JAMA; 2014 Sep 17; 312(11):1114-21. PubMed ID: 25226477
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug 17; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 7. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Spencer S, Evans DJ, Karner C, Cates CJ.
    Cochrane Database Syst Rev; 2011 Oct 05; (10):CD007033. PubMed ID: 21975759
    [Abstract] [Full Text] [Related]

  • 8. Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit?
    Man SF, Sin DD.
    Drugs; 2005 Oct 05; 65(5):579-91. PubMed ID: 15748094
    [Abstract] [Full Text] [Related]

  • 9. Should inhaled corticosteroids be used in the long term treatment of chronic obstructive pulmonary disease?
    Burge S.
    Drugs; 2001 Oct 05; 61(11):1535-44. PubMed ID: 11577791
    [Abstract] [Full Text] [Related]

  • 10. Inhaled corticosteroids for stable chronic obstructive pulmonary disease.
    Yang IA, Fong KM, Sim EH, Black PN, Lasserson TJ.
    Cochrane Database Syst Rev; 2007 Apr 18; (2):CD002991. PubMed ID: 17443520
    [Abstract] [Full Text] [Related]

  • 11. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM, Greenstone IR, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Apr 18; (2):CD005307. PubMed ID: 15846751
    [Abstract] [Full Text] [Related]

  • 12. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov 18; 25(176):272-277. PubMed ID: 30715829
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary disease.
    Sin DD, Johnson M, Gan WQ, Man SF.
    Curr Pharm Des; 2004 Nov 18; 10(28):3547-60. PubMed ID: 15579052
    [Abstract] [Full Text] [Related]

  • 14. Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a long-term benefit?
    Highland KB.
    Curr Opin Pulm Med; 2004 Mar 18; 10(2):113-9. PubMed ID: 15021180
    [Abstract] [Full Text] [Related]

  • 15. Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease.
    Sin DD, Man SF.
    Drugs Aging; 2003 Mar 18; 20(12):867-80. PubMed ID: 14565780
    [Abstract] [Full Text] [Related]

  • 16. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005535. PubMed ID: 16235410
    [Abstract] [Full Text] [Related]

  • 17. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A, Gessner C, Hoheisel G, Juergens U.
    Pneumologie; 2008 Jul 19; 62(7):430-7. PubMed ID: 18398787
    [Abstract] [Full Text] [Related]

  • 18. Common lung conditions: chronic obstructive pulmonary disease.
    Delzell JE.
    FP Essent; 2013 Jun 19; 409():23-31. PubMed ID: 23767419
    [Abstract] [Full Text] [Related]

  • 19. Long-term effects of inhaled corticosteroids on bone mineral density in older women with asthma or COPD: a registry-based cohort study.
    Chen W, Johnson KM, FitzGerald JM, Sadatsafavi M, Leslie WD.
    Arch Osteoporos; 2018 Oct 29; 13(1):116. PubMed ID: 30374631
    [Abstract] [Full Text] [Related]

  • 20. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
    Lee SY, Park HY, Kim EK, Lim SY, Rhee CK, Hwang YI, Oh YM, Lee SD, Park YB.
    Int J Chron Obstruct Pulmon Dis; 2016 Oct 29; 11():2797-2803. PubMed ID: 27877033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.